Differentiating vulvar intraepithelial neoplasia from nonneoplastic epithelial disorders. The toluidine blue test. 1998

E A Joura, and H Zeisler, and A Lösch, and M O Sator, and S Müllauer-Ertl
Department of Gynecology and Obstetrics, University of Vienna Medical School, Allgemeines Krankenhaus, Vienna, Austria.

OBJECTIVE To determine the effectiveness of the toluidine blue test in the differentiation of vulvar intraepithelial neoplasia (VIN) and nonneoplastic epithelial disorders (NNEDs). METHODS This retrospective clinical study included all women with VIN (n = 24) and NNED (n = 72) referred to a vulvar clinic at a university hospital during a two-year period. Vulvoscopy, staining of vulvar epithelium with 1% toluidine blue and punch biopsy were performed. RESULTS Vulvar epithelium demonstrated toluidine blue staining in 100% of the patients with VIN 3, in 83% of women with VIN 1-2, in 50% of the women with squamous cell hyperplasia and in 10% of the women with lichen sclerosus. The differences in staining between the groups were statistically significant (P < .001). The sensitivity of toluidine blue staining for the detection of VIN was 92%; the negative predictive value 96% in teh investigated cohort. The specificity for strong staining was 88%. CONCLUSIONS The toluidine blue test is an inexpensive and reliable method of separating VIN from hyperplastic NNED areas and choosing a biopsy site on the vulva.

UI MeSH Term Description Entries
D002278 Carcinoma in Situ A lesion with cytological characteristics associated with invasive carcinoma but the tumor cells are confined to the epithelium of origin, without invasion of the basement membrane. Carcinoma, Intraepithelial,Carcinoma, Preinvasive,Intraepithelial Neoplasms,Neoplasms, Intraepithelial,Intraepithelial Carcinoma,Intraepithelial Neoplasm,Neoplasm, Intraepithelial,Preinvasive Carcinoma
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001706 Biopsy Removal and pathologic examination of specimens from the living body. Biopsies
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D014048 Tolonium Chloride A phenothiazine that has been used as a hemostatic, a biological stain, and a dye for wool and silk. Tolonium chloride has also been used as a diagnostic aid for oral and gastric neoplasms and in the identification of the parathyroid gland in thyroid surgery. Toluidine Blue O,CI-52040,Toluidine Blue,Blue O, Toluidine,Blue, Toluidine,CI 52040,CI52040,Chloride, Tolonium
D014844 Vulva The external genitalia of the female. It includes the CLITORIS, the labia, the vestibule, and its glands. Vulvas

Related Publications

E A Joura, and H Zeisler, and A Lösch, and M O Sator, and S Müllauer-Ertl
August 1991, The American Journal of dermatopathology,
E A Joura, and H Zeisler, and A Lösch, and M O Sator, and S Müllauer-Ertl
November 1971, Obstetrics and gynecology,
E A Joura, and H Zeisler, and A Lösch, and M O Sator, and S Müllauer-Ertl
September 1982, Obstetrics and gynecology,
E A Joura, and H Zeisler, and A Lösch, and M O Sator, and S Müllauer-Ertl
January 2003, Medicina (Kaunas, Lithuania),
E A Joura, and H Zeisler, and A Lösch, and M O Sator, and S Müllauer-Ertl
May 2018, Ugeskrift for laeger,
E A Joura, and H Zeisler, and A Lösch, and M O Sator, and S Müllauer-Ertl
October 2014, Best practice & research. Clinical obstetrics & gynaecology,
E A Joura, and H Zeisler, and A Lösch, and M O Sator, and S Müllauer-Ertl
January 2011, Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti,
E A Joura, and H Zeisler, and A Lösch, and M O Sator, and S Müllauer-Ertl
August 2013, Zhonghua bing li xue za zhi = Chinese journal of pathology,
E A Joura, and H Zeisler, and A Lösch, and M O Sator, and S Müllauer-Ertl
March 2009, Zhonghua fu chan ke za zhi,
E A Joura, and H Zeisler, and A Lösch, and M O Sator, and S Müllauer-Ertl
June 2010, Acta obstetricia et gynecologica Scandinavica,
Copied contents to your clipboard!